home / stock / mdwd / mdwd news


MDWD News and Press, MediWound Ltd. From 11/10/20

Stock Information

Company Name: MediWound Ltd.
Stock Symbol: MDWD
Market: NASDAQ
Website: mediwound.com

Menu

MDWD MDWD Quote MDWD Short MDWD News MDWD Articles MDWD Message Board
Get MDWD Alerts

News, Short Squeeze, Breakout and More Instantly...

MDWD - MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2020 Results - Earnings Call Transcript

MediWound Ltd. (MDWD) Q3 2020 Results Conference Call November 10, 2020 08:30 AM ET Company Participants Jeremy Feffer - IR, LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Ryan Zimmerman - BTIG Raj Denhoy - Jefferies Kevin DeGeeter - Oppenheimer Josh Jen...

MDWD - MediWound EPS beats by $0.03, beats on revenue

MediWound (MDWD): Q3 GAAP EPS of -$0.07 beats by $0.03.Revenue of $6.63M (+29.0% Y/Y) beats by $0.84M.Press Release For further details see: MediWound EPS beats by $0.03, beats on revenue

MDWD - MediWound Reports Third Quarter 2020 Financial Results

Total Third Quarter R evenues of $6.6 Million Increased 29 % Y ear-over- Y ear Assigned PDUFA Goal Date of June 29, 2021 for NexoBrid BLA YAVNE, Israel, Nov. 10, 2020 (GLOBE NEWSWIRE) --  MediWound Ltd. (Nasd...

MDWD - MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020

YAVNE, Israel, Nov. 02, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the ...

MDWD - MediWound advances late-stage study of NexoBrid in pediatric burn patients

MediWound (MDWD) announces the completion of enrollment in a Phase 3 clinical trial evaluating NexoBrid in 145 patients younger than 18 years old with severe burns.The study will compare NexoBrid (concentrate of proteolytic enzymes enriched in Bromelain), a topically administered biologic tha...

MDWD - MediWound Completes Enrollment Stage of its NexoBrid Phase 3 Pediatric Study

YAVNE, Israel, Oct. 28, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced it has completed the enrollment stage of its NexoBrid ...

MDWD - MediWound Studying the Effect of EscharEx on Biofilm Burden

YAVNE, Israel, Oct. 14, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) ("MediWound”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that it is exploring the pharmacologica...

MDWD - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

MDWD - 3 Small-cap Stocks with Enormous Growth Potential

Pacific Ethanol (PEIX), Great Panther Mining (GPL), and MediWound (MDWD) are three small-cap stocks that have high earnings and revenue growth potential. With a potential rotation from tech to small-caps, these stocks are the likeliest to outperform. Growth has been outperforming value q...

MDWD - MediWound (MDWD) Investor Presentation - Slideshow

The following slide deck was published by MediWound Ltd. in conjunction with this Read more ...

Previous 10 Next 10